BHC Stock Summary and Trading Ideas (Bausch Health Companies | NYSE:BHC)

Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum of its revenue from the Bausch + Lomb segment.

Bausch Health Companies trades on the NYSE stock market under the symbol BHC.

As of November 11, 2026, BHC stock price climbed to $8.35 with 2,252,160 million shares trading.

BHC has a beta of 1.00, meaning it tends to be less sensitive to market movements. BHC has a correlation of 0.04 to the broad based SPY ETF.

BHC has a market cap of $3.12 billion. This is considered a Mid Cap stock.

Last quarter Bausch Health Companies reported $3 billion in Revenue and $1.77 earnings per share. This beat revenue expectation by $187 million and exceeded earnings estimates by $.56.

In the last 3 years, BHC traded as high as $11.46 and as low as $3.96.

The top ETF exchange traded funds that BHC belongs to (by Net Assets): DFIS, DFIC, DISV, DFAX, ISCF.

BHC has outperformed the market in the last year with a price return of +30.5% while the SPY ETF gained +12.6%. BHC has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +31.5% and +32.3%, respectively, while the SPY returned -1.5% and -1.3%, respectively.

BHC support price is $8.02 and resistance is $8.56 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that BHC shares will trade within this expected range on the day.